Pfizer - International Biopharmaceutical Industry

news

Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024

Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the Europea...

23 September 2024 news oncology | Pfizer

Continue Reading →

news

Pfizer Quickly Expands its Hemophilia B Gene Therapy’s Reach with EU Approval

Three months after bagging FDA approval, Pfizer’s hemophilia B gene therapy has been cleared to expand its reach across the pond. The therapy, which is branded as...

29 July 2024 news gene therapy | hemophilia B

Continue Reading →

news

GSK wagers $2.1B on Affinivax and its next-generation pneumonia vaccine

GSK has agreed to acquire Affinivax in a deal announced Tuesday, betting more than $3 billion that the eight-year-old startup’s technology can lead to a more effectiv...

6 June 2022 news Affinivax | GSK

Continue Reading →

news

Pfizer to exit GSK consumer health joint venture after spinoff

Dive Brief: Pfizer plans to sell its shares in a consumer health joint venture with GlaxoSmithKline after the business is spun off into a new standalone corporatio...

6 June 2022 news consumer | GSK

Continue Reading →

news

Pfizer to acquire Biohaven in $11.6B bet on biotech’s migraine drugs

Pfizer has agreed to acquire Biohaven Pharmaceuticals for $11.6 billion in a deal that turns an existing alliance on a fast-selling migraine drug into a big bet on it...

13 May 2022 news Biohaven | Drugs

Continue Reading →

news

UK bid to battle antibiotic resistance yields first subscription-style plan

The U.K. took a small step forward in its efforts to spur development of new antibiotics, announcing on Tuesday a plan to pay Pfizer and Shionogi roughly $13 million ...

14 April 2022 news antibiotic | Pfizer

Continue Reading →

news

Pfizer buys a private biotech and its RSV drug research

Dive Brief: Pfizer said Thursday it will spend as much as $525 million to buy the privately held biotech ReViral, adding experimental treatments for respiratory sy...

11 April 2022 news Biotech | Drug

Continue Reading →

news

Pfizer claims study success for drug key to Arena buyout

Dive Brief: Pfizer said Wednesday an experimental drug central to its $7 billion purchase of Arena Pharmaceuticals succeeded in a crucial Phase 3 trial in patients...

25 March 2022 news Arena | colitis

Continue Reading →

news

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Dive Brief: Alnylam is accusing Pfizer and Moderna of violating a patent it holds for technology that Alnylam claims the two companies use in their respective COVI...

21 March 2022 news Alnylam | COVID

Continue Reading →

news

Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Dive Brief: Moderna has asked the Food and Drug Administration to clear a fourth dose of its COVID-19 vaccine for adults 18 and over, a broader request than Pfizer...

21 March 2022 news adults | BioNTech

Continue Reading →